1 most recent filing and news item mentioning PVCT. Updated every 60 seconds.
OtherJun 18, 2026Neutral
Provectus Biopharmaceuticals submitted an exhibit filing with the SEC. The filing contains material information relevant to investors in the biopharmaceutical company.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.